SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE
SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE is the same as attribute SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE.
Format / Length
max an5
Description
SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE is the same as attribute SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE.
National Codes
Code | Description |
---|---|
A1 |
Primary syphilis |
A2 |
Secondary syphilis |
A3 |
Early latent syphilis |
A4 |
Cardiovascular syphilis |
A5 |
Neurosyphilis |
A6 |
All other late and latent syphilis |
A7A |
Congenital syphilis |
A10 |
Ocular syphilis |
A11 |
Otosyphilis |
B |
Gonorrhoea |
C1 |
Chancroid |
C2 |
Lymphogranuloma venereum (LGV) |
C3 |
Donovanosis |
C4 |
Chlamydial infection |
C4N |
Non-specific genital infection (NSGI) |
C5A |
Pelvic inflammatory disease (PID) and epididymitis |
C5B |
Ophthalmia neonatorum |
C6A |
Trichomoniasis |
C6B |
Anaerobic/Bacterial vaginosis and anaerobic balanitis |
C6C |
Other vaginosis/vaginitis/balanitis |
C7A |
Anogenital candidosis |
C8 |
Scabies |
C9 |
Pediculosis pubis |
C10A |
Anogenital Herpes simplex: First episode |
C10B |
Anogenital Herpes simplex: Recurrent episode |
C11A |
Anogenital warts infection: First episode |
C11D |
Anogenital warts infection: Recurrent episode |
C12 |
Molluscum contagiosum |
C13 |
Viral hepatitis B (HbsAg positive): First diagnosis |
C14 |
Viral hepatitis C: First diagnosis |
C15 |
Viral hepatitis A: Acute infection |
C16 |
Mycoplasma genitalium |
D2A |
Urinary Tract Infection |
D2B |
Other conditions requiring treatment at Level 3 Genitourinary Medicine Services |
H |
HIV positive - Previously Diagnosed |
H1 |
New HIV diagnosis |
H1A |
New HIV diagnosis: Acute |
H1B |
New HIV diagnosis: Late infection (AIDS defined) |
H2 |
Attendance for HIV-related care |
P4A |
Cervical cytology: minor abnormality |
P4B |
Cervical cytology: major abnormality |
T1 |
Chlamydia test |
T2 |
Chlamydia and gonorrhoea tests |
T3 |
Chlamydia, gonorrhoea and syphilis tests |
T4 |
Chlamydia, gonnorrhoea, syphilis and HIV antibody tests |
T5 |
Herpes Simplex Virus (HSV) Test |
T6 |
Hepatitis A/B/C Test |
TS |
Microscopy |
TT |
3 Site Testing (chlamydia and gonorrhoea) |
T7 |
Syphilis and HIV Testing |
T8 |
Self sampling (urinalysis/swabs) without Health Care worker (HCW) consultation |
T9 |
STI testing not required/appropriate |
T10 |
Rapid testing (STI and/or HIV) |
T11 |
Chlamydia test declined |
T12 |
Mycoplasma genitalium test |
O20 |
Hepatitis A vaccination: 1st dose |
O21 |
Hepatitis A vaccination: Subsequent dose |
O22 |
Hepatitis A immune |
O23 |
Partner notification related attendance: Hepatitis A contact |
O31 |
PrEP eligibility criteria 1: MSM/transgender woman |
O32 |
PrEP eligibility criteria 2: HIV positive partner |
O33 |
PrEP eligibility criteria 3: Other high risk |
O41 |
PrEP regimen: Starting or continuing daily Prep |
O42 |
PrEP regimen: Starting or continuing event based Prep |
O43 |
PrEP regimen: Continued through other source |
O44 |
PrEP regimen: Offered and declined |
O45 |
PrEP regimen: Stopped |
O51 |
PrEP prescription: 30 tablets |
O52 |
PrEP prescription: 60 tablets |
O53 |
PrEP prescription: 90 tablets |
O60 |
PrEP patient characteristic: Transgender |
P1A |
Human Immunodeficiency Virus (HIV) antibody test (no sexual health screen) |
P1B |
Human Immunodeficiency Virus (HIV) antibody test offered and refused |
P1C |
HIV test inappropriate |
P2A |
Hepatitis B vaccination: 1st dose |
P2B |
Hepatitis B vaccination: 2nd dose |
P2C |
Hepatitis B vaccination: 3rd dose |
P2D |
Hepatitis B vaccination: 4th dose |
P2E |
Hepatitis B vaccination: Booster |
P2I |
Hepatitis B immune |
P3 |
CONTRACEPTION
and family planning advice (excluding condom provision) |
P4 |
Cervical cytology done |
REF1 |
Referral from Chlamydia Screening Programme |
REF2 |
Referral to a Level 3 Genitourinary Medicine Service |
REF3 |
Referral from home testing/sampling service |
SG1 |
Shigella flexneri (group B) |
SG2 |
Shigella sonnei (group D) |
SG3 |
Shigella other/unspecified |
SRH |
Sexual and Reproductive Health PATIENT |
W1 |
HPV vaccination: 1st dose |
W2 |
HPV vaccination: 2nd dose |
W3 |
HPV vaccination: 3rd dose |
W4 |
HPV vaccination: offered and declined |
W5 |
HPV vaccination: previously received in full |
PN |
Partner notification initiated related attendance |
PNC |
Partner notification related attendance: Chlamydia contact |
PNG |
Partner notification related attendance: Gonorrhoea contact |
PNH |
Partner notification related attendance: HIV contact |
PNN |
Partner notification related attendance: Non-specific genital infection contact |
PNP |
Partner notification related attendance: PID/Epididymitis contact |
PNS |
Partner notification related attendance: Syphilis contact |
PNT |
Partner notification related attendance: Trichomoniasis contact |
PR1 |
Pregnant 1-12 weeks |
PR2 |
Pregnant 13-28 weeks |
PR3 |
Pregnant 29-40 weeks |
PEPS |
Post exposure prophylaxis after sexual exposure (PEPSE) |
D3 |
Other Sexual Health and HIV Episodes not requiring treatment |
O11-O99 |
Research/New/Urgent reporting (Retired 01 October 2018) |
40 |
Sexual Assault (Acute presentation) |
41 |
Sexual Assault (Non - acute presentation) |
CSE1 |
Child sexual exploitation : concerns raised at internal assessment |
CSE2 |
Child sexual exploitation : concerns raised with internal safeguarding professionals |
CSE3 |
Child sexual exploitation : referred to external safeguarding professionals |
DV |
Concern of domestic violence (or abuse) |
FGM |
Female genital mutilation (of any type) |
Z |
Prisoner |
SW |
Sex Worker |
R |
Rectal infection |
O |
Pharyngeal infection |
X |
Previously diagnosed elsewhere |
M |
Medication given |
Q |
Quadrivalent HPV vaccine |
A1X |
Primary syphilis - previously diagnosed elsewhere |
A2X |
Secondary syphilis - previously diagnosed elsewhere |
A3X |
Early latent syphilis - previously diagnosed elsewhere |
A4X |
Cardiovascular syphilis - previously diagnosed elsewhere |
A5X |
Neurosyphillis syphilis - previously diagnosed elsewhere |
A6X |
All other late and latent syphilis - previously diagnosed elsewhere |
A7AX |
Congenital syphilis - previously diagnosed elsewhere |
BR |
Gonorrhoea - rectal infection |
BO |
Gonorrhoea - pharayngeal infection |
BX |
Gonorrhoea - previously diagnosed elsewhere |
BM |
Gonorrhoea - medication given |
BRX |
Gonorrhoea - rectal infection, previously diagnosed elsewhere |
BRM |
Gonorrhoea - rectal infection, medication given |
BOX |
Gonorrhoea - pharayngeal infection, previously diagnosed elsewhere |
BOM |
Gonorrhoea - pharayngeal infection, medication given |
C4R |
Chlamydia - rectal infection |
C4O |
Chlamydia - pharayngeal infection |
C4X |
Chlamydia - previously diagnosed elsewhere |
C4M |
Chlamydia - medication given |
C4RX |
Chlamydia - rectal infection, previously diagnosed elsewhere |
C4RM |
Chlamydia - rectal infection, medication given |
C4OX |
Chlamydia - rectal infection, previously diagnosed elsewhere |
C4OM |
Chlamydia - pharayngeal infection, medication given |
C2R |
Lymphogranuloma venereum (LGV) - Rectal infection |
C2O |
Lymphogranuloma venereum (LGV) - Pharayngeal infection |
C4NR |
Non-specific genital infection (NSGI) - rectal infection (proctitis) |
C6AX |
Trichomoniasis - previously diagnosed elsewhere |
H1X |
New HIV diagnosis - previously diagnosed elsewhere |
H1AX |
New HIV diagnosis: acute - previously diagnosed elsewhere |
H1BX |
New HIV diagnosis: late (AIDS defined) - previously diagnosed elsewhere |
C10AM |
Anogenital Herpes simplex: first episode - medication given |
C10BM |
Anogenital Herpes simplex: recurrent episode - medication given |
C11AM |
Anogenital warts infection: first episode - medication given |
C11DM |
Anogenital warts infection: recurrent episode - medication given |
W1Q |
HPV Vaccination: 1st dose - quadrivalent vaccine |
W2Q |
HPV Vaccination: 2nd dose - quadrivalent vaccine |
W3Q |
HPV Vaccination: 3rd dose - quadrivalent vaccine |
Also Known As
This data element is also known by these names:
Context | Alias |
---|---|
Formerly | GENITOURINARY EPISODE TYPE |
Plural | SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPES |
Where Used
Type | Link | How used |
---|---|---|
Data Set | GUMCAD Sexually Transmitted Infection Surveillance System Data Set | references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE |
Data Element | SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE | references in description SEXUAL HEALTH AND HIV ACTIVITY PROPERTY TYPE |